Recent Articles from GlobeNewswire

FirstService to Announce Fourth Quarter and Annual Results for 2025 on February 4, 2026
TORONTO, Jan. 14, 2026 (GLOBE NEWSWIRE) -- FirstService Corporation (TSX and NASDAQ: FSV) (“FirstService”) announced today that it will release its financial results for the fourth quarter ended December 31, 2025 by press release on Wednesday, February 4, 2026 at approximately 7:30 am ET.
By FirstService Corporation · Via GlobeNewswire · January 14, 2026
AirJoule Technologies Announces Pricing of $20 Million Public Offering of Class A Common Stock
RONAN, Mont., Jan. 14, 2026 (GLOBE NEWSWIRE) -- AirJoule Technologies Corporation (NASDAQ: AIRJ) (“AIRJ” or the “Company”) today announced the pricing of an underwritten public offering of 6,153,847 shares of its Class A common stock, par value $0.0001 per share (“Class A common stock”), at a public offering price of $3.25 per share, pursuant to an effective shelf registration statement on Form S-3 (File No. 333-291527) (the “Registration Statement”) previously filed with the U.S. Securities and Exchange Commission (the “SEC”).
By AirJoule Technologies Corporation · Via GlobeNewswire · January 14, 2026
Big Sound, Small Form Factor, Stylish Design: Cyber Acoustics Announces the CA-2110USB Desktop Speakers
Add an elegant touch to your work space
By Cyber Acoustics, Inc. · Via GlobeNewswire · January 14, 2026
NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval
WILMINGTON, Del., Jan. 14, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical company, today announced that it has licensed Real World Evidence (RWE) drawn from over 70,000 patients in the United States who were treated with either intravenous ketamine or nasal S-ketamine for depression and suicidal ideation. The information is being submitted in support of NRx’s application for Accelerated Approval of NRX-100 (preservative-free ketamine) under Fast Track Designation for Treatment of Suicidal Ideation in Depression and Bipolar Depression. Currently, there is no medicine approved to treat suicidal ideation and the only FDA-approved treatment today is Electroshock Therapy.
By NRx Pharmaceuticals, Inc. · Via GlobeNewswire · January 14, 2026
Prospect Enhanced Yield Fund Announces 9.05% Annualized Total Cash Distribution Rate (on Net Asset Value) for January through March 2026
NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Prospect Enhanced Yield Fund (“PENF” or the “Fund”) announced today that the Fund’s Board of Directors has declared monthly cash shareholder distributions for January 2026, February 2026, and March 2026. These distributions represent the fourth, fifth, and sixth monthly distributions paid by the Fund.
By Prospect Enhanced Yield Fund · Via GlobeNewswire · January 14, 2026
SEMCAP Food & Nutrition Announces $125 Million Close of Inaugural Fund
PHILADELPHIA and MINNEAPOLIS, Jan. 14, 2026 (GLOBE NEWSWIRE) -- SEMCAP Food & Nutrition is pleased to announce the close of its inaugural Food & Nutrition fund with commitments totaling $125 million. This first fundraise draws on an investor base that includes some of the most strategic investors and food brokers in the industry, underscoring growing global demand for sustainable, better-for-you food companies.
By SEMCAP Food & Nutrition · Via GlobeNewswire · January 14, 2026
Is Data Analytics the Key to Success? YES: Dmitry Shubov Explains Why Businesses Need Data-Driven Insights for Optimal Results
FREMONT, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Many Southeast Asian (SEA) businesses have made it a goal to expand into the U.S. market in 2026. One key factor supporting this is data-driven insights. According to the Gartner 2025 Data and Analytics Report, covered by the National CIO Review, businesses that can strategically use data analytics have a substantially better chance of making informed decisions and positioning the company effectively.
By Dmitry Shubov Consulting · Via GlobeNewswire · January 14, 2026
C4 Therapeutics Outlines Strategic Milestones to Advance Cemsidomide as a Potential Best-in-Class IKZF1/3 Degrader and Discovery Strategy Focused on Novel Targets in Clinically Validated Pathways
 Cemsidomide Phase 2 MOMENTUM Trial On Track to Initiate in Q1 2026; Recommended Phase 2 Dose is 100 µg
By C4 Therapeutics, Inc. · Via GlobeNewswire · January 14, 2026
Eos Energy Announces Indensity™: A Breakthrough in Battery Energy Storage—Join the Launch Event Today at 8:30 a.m. ET
PITTSBURGH, Pa., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (NASDAQ: EOSE) ("Eos" or the “Company”), an American energy company and the leading innovator in designing, sourcing, manufacturing, and providing zinc-based battery energy storage systems (BESS), today announced the launch of Eos Indensity™—and invites you to experience it first during an unveiling event happening today at 8:30 a.m. ET. Register now and be part of the future of energy storage.
By Eos Energy Enterprises, Inc. · Via GlobeNewswire · January 14, 2026
Skyharbour Intersects High-Grade Uranium in Drill Hole ML25-15 at the Maverick Main Zone Returning 11.77% U3O8 over 1.6 metres within 4.4 metres of 4.84% U3O8 and Identifies a New Prospective Regional Target Area called Nomad at the Moore Project
Vancouver, BC, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (“Skyharbour” or the “Company”) is pleased to announce results from its 2025 drilling campaign at its 100% owned 35,705 hectare Moore Uranium Project, located approximately 15 kilometres east of Denison Mines’ Wheeler River project in the Athabasca Basin, Saskatchewan. A total of twenty-one drill holes were completed totaling 7,884 metres in the latter part of last year. The drilling notably intersected high-grade uranium mineralization at the Main Maverick Zone with hole ML25-15, returning 4.84% U3O8 over 4.4 metres, including 11.77% U3O8 over 1.6 metres. Furthermore, Skyharbour successfully identified a new regional target area called the Nomad Zone approximately 1.7 kilometres to the southwest of the Main Maverick Zone. The exploratory drilling at this new target intersected extensive sandstone and basement faulting accompanied by intense hydrothermal alteration, collectively underscoring a fertile environment with strong potential for additional uranium discoveries.
By Skyharbour Resources Ltd · Via GlobeNewswire · January 14, 2026
OTC Markets Group Welcomes Cannara Biotech Inc. to OTCQX
NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Cannara Biotech Inc. (TSX-V: LOVE.V; OTCQX: LOVFF FSX: 8CB;), a vertically integrated producer of premium-grade cannabis and cannabis-derivative products, has qualified to trade on the OTCQX® Best Market. Cannara Biotech Inc. upgraded to OTCQX from the OTCQB® Venture Market.
By OTC Markets · Via GlobeNewswire · January 14, 2026
Equinox Gold Delivers Record Q4 Production and Record FY 2025 Gold Production of 922,827 ounces; 2026 Guidance Represents an 80% Increase in Annual Canadian Gold Production
VANCOUVER, British Columbia, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Equinox Gold Corp. (TSX: EQX, NYSE American: EQX) (“Equinox Gold” or the “Company”) is pleased to announce production results for the three months (“Q4”) and year (“Full Year”) ended December 31, 2025, an update on operations at its two Canadian cornerstone assets (Greenstone Gold Mine (“Greenstone”) and Valentine Gold Mine (“Valentine”) and its 2026 production, cost and capital guidance. The Company’s audited financial and operating results for Q4 and Full Year 2025 will be released on Wednesday, February 18, 2026 after market close. All financial figures in this news release are in US dollars.
By Equinox Gold Corp. · Via GlobeNewswire · January 14, 2026
Goliath Resources Selected For Core Shack, AME Roundup 2026 – Booth #1026C, Also Attending VRIC – Booth #131 And Metals Investors Forum In Vancouver
TORONTO, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Goliath Resources Limited (TSX-V: GOT) (OTCQB: GOTRF) (FSE: B4IF) (the “Company” or “Goliath”) is focused on further expanding its new high-grade gold Surebet Discovery at its 100% controlled Golddigger Property that covers an area of 91,518 hectares in a highly prospective geological setting of the Eskay Rift, within 3 kilometers of the Red Line in the Golden Triangle of British Columbia. This area, in close proximity to the Red Line, has hosted some of Canada’s greatest gold mines including Eskay Creek, Premier and Snip. Other significant and well-known deposits in the Golden Triangle include Brucejack, Copper Canyon, Galore Creek, Granduc, KSM, Red Chris, and Schaft Creek. Goliath controls 56 kilometers of the Red Line which is a geologic contact between Triassic age Stuhini rocks and Jurassic age Hazelton rocks used as key markers when exploring for gold-copper-silver mineralization.
By Goliath Resources Limited · Via GlobeNewswire · January 14, 2026
Mars Veterinary Health Publishes 2025 Science Impact Report Highlighting Global Advances in Pet Health
One of the world’s leading contributors of veterinary research details how its data-driven insights and global scientific advancements are shaping the future of veterinary medicine
By Mars Veterinary Health · Via GlobeNewswire · January 14, 2026
RetinalGenix Reports on its Science and Mission in Light of New AI-Driven Retinal Mapping Study
APOLLO BEACH, Fla., Jan. 14, 2026 (GLOBE NEWSWIRE) -- RetinalGenix Technologies Inc. [OTCQB: RTGN] (“RetinalGenix” or the “Company”), a company developing ultra-high-resolution retinal imaging technology, today announced that a recent large‑scale Australian retinal mapping study, which used artificial intelligence to analyze approximately 50,000 retinal scans, reported that specific patterns of retinal thinning are associated with neurodegenerative and metabolic diseases such as dementia, diabetes, and multiple sclerosis. These findings support the broader field of oculomics and reinforce the premise that high‑quality retinal images, analyzed with advanced algorithms and integrated with genetic and clinical data, could become an important tool for earlier detection, risk stratification, and ongoing monitoring of disease. RetinalGenix’s core thesis—that combining high‑resolution imaging, genetics, and advanced analytics may unlock new insights into ocular and systemic health—is expected to position the Company to benefit as this field continues to mature.
By RetinalGeniX Technologies, Inc. · Via GlobeNewswire · January 14, 2026
Ragnarok X: Next Generation Official Launching in France, Italy, Germany, the Middle East, Egypt and Algeria on January 14, 2026
Seoul, South Korea, Jan. 14, 2026 (GLOBE NEWSWIRE) -- GRAVITY Co., Ltd. (NasdaqGM: GRVY) (“Gravity” or “Company”), a developer and publisher of online and mobile games, announced that GRAVITY Game Hub PTE., Ltd. (“Gravity Game Hub”), Gravity's wholly-owned subsidiary, has officially launched Ragnarok X: Next Generation, an MMORPG Mobile and PC game, in France, Italy, Germany, the Middle East, Egypt and Algeria on January 14, 2026.
By GRAVITY Co., Ltd. · Via GlobeNewswire · January 14, 2026
MEXC Begins 2026 with Strong Reserves: January Audit Shows BTC Coverage at 158%
By MEXC · Via GlobeNewswire · January 14, 2026
FAU Research Finds Investors Are Shifting Toward ‘Positive’ ESG Screening
BOCA RATON, Fla., Jan. 14, 2026 (GLOBE NEWSWIRE) --  Investors show a stronger preference for positive environmental, social and governance (ESG) screening, especially in times of uncertainty in stock markets, according to a new study from researchers at Florida Atlantic University.
Gemba Appoints Fintech Veteran Georg Hauer as Strategic Advisor for Global Scaling and Regulatory Expansion
LONDON, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Gemba Finance Ltd ("Gemba"), the leading UK-based banking infrastructure and embedded finance platform, today announced the appointment of Georg Hauer, the former General Manager of N26 and COO/CFO of Hawk AI, as strategic advisor. Hauer will support Gemba’s executive leadership on scaling operations, navigating complex regulatory landscapes, and accelerating expansion strategies for the UK, European Union, and United States markets.
By Gemba Finance Ltd · Via GlobeNewswire · January 14, 2026
WeRide Makes Robotaxi Booking Effortless via Tencent's Super-app WeChat in China
GUANGZHOU, China, Jan. 14, 2026 (GLOBE NEWSWIRE) -- WeRide (NASDAQ: WRD, HKEX: 0800), a global leader in autonomous driving technology, today launched its Robotaxi service Mini Program, "WeRide Go", on WeChat, a super-app owned by tech giant Tencent. WeChat is one of China's most widely used digital platforms, with over a billion users.
By WeRide Inc. · Via GlobeNewswire · January 14, 2026
Bitget Captures 89% Tokenized Stock Market Share in December, Extends 0 Fee Trading Through April 2026
By Bitget Limited · Via GlobeNewswire · January 14, 2026
Inside information: Orion provides outlook for 2026 and estimates that the annual Nubeqa® net sales recorded by Orion has potential to exceed EUR 1 billion in the future
ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION 14 JANUARY 2026 at 8:30 EET        
By Orion Oyj · Via GlobeNewswire · January 14, 2026
WISeKey’s Subsidiary, SEALSQ Announces Entry into a Memorandum of Understanding Regarding a Potential Strategic Investment and Acquisition of Quantum Computing Firm Quobly
WISeKey’s Subsidiary, SEALSQ Announces Entry into a Memorandum of Understanding Regarding a Potential Strategic Investment and Acquisition of Quantum Computing Firm Quobly
TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale
MUMBAI, India and SANTA CLARA, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Tata Consultancy Services (TCS) (BSE: 532540, NSE: TCS), a global leader in IT services, consulting, and business solutions, today announced a strategic collaboration with AMD (NASDAQ: AMD) to help enterprises scale AI adoption from pilots to production, modernize legacy environments, and build secure, high performance digital workplaces.
By Advanced Micro Devices, Inc. · Via GlobeNewswire · January 14, 2026
New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS
PARIS, FRANCE, 14 JANUARY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today the presentation of 14 across multiple neurological conditions at the TOXINS 2026 conference (14-17 January) in Madrid, Spain. Data presented highlighted the depth and diversity of evidence across multiple movement disorders — including post‑stroke spasticity, cervical dystonia and blepharospasm, adding to the available evidence of Dysport®(abobotulinumtoxinA) in patient care – alongside new indications under evaluation.
By Ipsen Pharma · Via GlobeNewswire · January 14, 2026
HUTCHMED Highlights Publication of Phase III SACHI Results in The Lancet
— First randomized Phase III trial confirming the efficacy of MET inhibition in patients with advanced NSCLC and acquired MET amplification after progression on prior EGFR-TKI treatment —
By HUTCHMED (China) Limited · Via GlobeNewswire · January 13, 2026
Bitget’s 2025 Review: UEX Leads the Convergence of Crypto and Traditional Markets
By Bitget Limited · Via GlobeNewswire · January 13, 2026
CORRECTION – Visionary Holdings Inc.
TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- In a release issued under the headline "Visionary Holdings Inc. Reports Fiscal Year 2025 Annual Report" on Monday, January 12th by Visionary Holdings Inc. (Nasdaq: GV), please be advised that the headline and content have been updated to accurately reflect comments from the U.S. Securities and Exchange Commission. The corrected release follows:
By Visionary Holdings Inc. · Via GlobeNewswire · January 13, 2026
Klarna Group plc Securities Class Action Result of Understated Risks and Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
NEW YORK and NEW ORLEANS, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until February 20, 2026 to file lead plaintiff applications in a securities class action lawsuit against Klarna Group plc (NYSE: KLAR), if they purchased the Company’s securities pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Registration Statement”) issued in connection with Klarna’s September 2025 initial public offering (the “IPO”). This action is pending in the United States District Court for the Eastern District of New York.
By Kahn Swick & Foti, LLC · Via GlobeNewswire · January 13, 2026
DeFi Technologies Inc. Notice of January 30, 2026 Application Deadline for Class Action Lawsuit- Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
NEW YORK and NEW ORLEANS, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in DeFi Technologies Inc. (“DeFi” or the “Company”) (NasdaqCM: DEFT) of a class action securities lawsuit.
By Kahn Swick & Foti, LLC · Via GlobeNewswire · January 13, 2026
Jayud Global Logistics Ltd. Notice of January 20, 2026 Application Deadline for Class Action Lawsuit- Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
NEW YORK and NEW ORLEANS, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Jayud Global Logistics Limited (“Jayud” or the “Company”) (NasdaqCM: JYD) of a class action securities lawsuit.
By Kahn Swick & Foti, LLC · Via GlobeNewswire · January 13, 2026
Bitdeer Technologies Group Securities Fraud Class Action Result of Undisclosed Financial Problems and 14% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
NEW YORK and NEW ORLEANS, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until February 2, 2026 to file lead plaintiff applications in a securities class action lawsuit against Bitdeer Technologies Group (“Bitdeer” or the "Company") (NasdaqCM: BTDR), if they purchased or otherwise acquired the Company’s securities between June 6, 2024 and November 10, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
By Kahn Swick & Foti, LLC · Via GlobeNewswire · January 13, 2026
Integer Holdings Corporation Securities Fraud Class Action Result of Undisclosed Financial Problems and 32% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
NEW YORK and NEW ORLEANS, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until February 9, 2026 to file lead plaintiff applications in a securities class action lawsuit against Integer Holdings Corporation (“Integer” or the “Company”) (NYSE: ITGR), if they purchased or otherwise acquired the Company’s shares between July 25, 2024 and October 22, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
By Kahn Swick & Foti, LLC · Via GlobeNewswire · January 13, 2026
Alexandria Real Estate Equities Securities Fraud Class Action Result of Financial Issues and Approximately 19% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
NEW YORK and NEW ORLEANS, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until January 26, 2026 to file lead plaintiff applications in a securities class action lawsuit against Alexandria Real Estate Equities, Inc. (“Alexandria” or the “Company”) (NYSE: ARE), if they purchased or otherwise acquired the Company’s securities between January 27, 2025 to October 27, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Central District of California.
By Kahn Swick & Foti, LLC · Via GlobeNewswire · January 13, 2026
Sprouts Farmers Market, Inc. Securities Fraud Class Action Result of Undisclosed Financial Problems and 26% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
NEW YORK and NEW ORLEANS, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until January 26, 2026 to file lead plaintiff applications in a securities class action lawsuit against Sprouts Farmers Market, Inc. (“Sprouts” or the “Company”) (NasdaqGS: SFM), if they purchased or otherwise acquired the Company’s securities between June 4, 2025 and October 29, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Arizona.
By Kahn Swick & Foti, LLC · Via GlobeNewswire · January 13, 2026
F5, Inc. Securities Fraud Class Action Result of Data Breach and Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
NEW YORK and NEW ORLEANS, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until February 17, 2026 to file lead plaintiff applications in a securities class action lawsuit against F5, Inc. (NasdaqGS: FFIV), if they purchased or otherwise acquired the Company’s securities between October 28, 2024, and October 27, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Western District of Washington.
By Kahn Swick & Foti, LLC · Via GlobeNewswire · January 13, 2026
Ardent Health Corporation Securities Fraud Class Action Result of Undisclosed Financial Problems and 33% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
NEW YORK and NEW ORLEANS, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until March 9, 2026 to file lead plaintiff applications in a securities class action lawsuit against Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT), if they purchased or otherwise acquired the Company’s securities between July 18, 2024 and November 12, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Middle District of Tennessee.
By Kahn Swick & Foti, LLC · Via GlobeNewswire · January 13, 2026
Coupang, Inc. Securities Fraud Class Action Result of Data Breach and Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
NEW YORK and NEW ORLEANS, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until February 17, 2026 to file lead plaintiff applications in securities class action lawsuits against Coupang, Inc. (NYSE: CPNG), if they purchased or otherwise acquired the Company’s securities between May 7, 2025 and December 16, 2025, inclusive (the “Class Period”). These actions are pending in the United States District Courts for the Northern District of California and Western District of Washington.
By Kahn Swick & Foti, LLC · Via GlobeNewswire · January 13, 2026
Bitdeer AI Accelerates Global AI Cloud Expansion with NVIDIA GB200 NVL72 Deployment
SINGAPORE, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Bitdeer AI, part of Bitdeer Technologies Group (NASDAQ: BTDR), an emerging AI cloud service provider and NVIDIA Cloud Partner, today announced the launch of its NVIDIA GB200 NVL72 deployment in Malaysia, marking a new chapter in the company’s mission to simplify and scale AI computing globally.
By Bitdeer AI · Via GlobeNewswire · January 13, 2026
FUJIFILM Announces Instax mini Evo Cinema Hybrid Instant Camera; Preorder at B&H
Fujifilm has unveiled the latest addition to their instant camera arsenal with the retro designed Instax mini Evo Cinema. This is the first instant video capable camera in the Instax line and a great 3-in-1 camera for the photo/video enthusiast.
By B&H Photo Video · Via GlobeNewswire · January 13, 2026
NOVAGOLD Announces Appointment of Project Director to Lead Advancement of the Donlin Gold Project
VANCOUVER, British Columbia, Jan. 13, 2026 (GLOBE NEWSWIRE) -- NOVAGOLD RESOURCES INC. (“NOVAGOLD” or the “Company”) (NYSE American, TSX: NG) is pleased to announce the appointment of Frank Arcese as Project Director to Donlin Gold LLC (“Donlin Gold”), bringing more than four decades of global project leadership to Donlin Gold. This hiring further strengthens the team as we prepare to launch the work on the Bankable Feasibility Study (BFS) and progress the project toward development.
By NOVAGOLD RESOURCES INC. · Via GlobeNewswire · January 13, 2026
AWLC Announces Pricing of $500 Million of 4.625% Senior Notes Due 2028 and $750 Million of 5.250% Senior Notes Due 2033
NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- ATLAS SP Partners (“ATLAS”), the warehouse finance and securitized products business majority owned by Apollo funds, today announced the pricing of an offering of $500 million in aggregate principal amount of additional 4.625% senior notes due 2028 (the “Add-On Notes”) and $750 million in aggregate principal amount of 5.250% senior notes due 2033 (the “New Notes” and, together with the Add-On Notes, the “Notes”) by Atlas Warehouse Lending Company, L.P. (“AWLC”) in a private offering under Rule 144A of the Securities Act of 1933, as amended (the “Securities Act”) to eligible purchasers (the “Offering”).
By ATLAS SP Partners · Via GlobeNewswire · January 13, 2026
ROSEN, THE FIRST FILING FIRM, Encourages agilon health, inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AGL
NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · January 13, 2026
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages DeFi Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DEFT
NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · January 13, 2026
KLAR DEADLINE ALERT: Klarna Group plc Investors Urged to Contact Kirby McInerney LLP About Class Action Lawsuit
NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds Klarna Group plc (“Klarna” or the “Company”) (NYSE:KLAR) investors of the February 20, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action.
By Kirby McInerney LLP · Via GlobeNewswire · January 13, 2026
JYD INVESTORS: Contact Kirby McInerney LLP About Securities Class Action Lawsuit On Behalf of Jayud Global Logistics
NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds Jayud Global Logistics Limited (“Jayud” or the “Company”) (NYSE:JYD) investors of the January 20, 2026 deadline to seek lead plaintiff appointment in the class action filed on behalf of investors who acquired Jayud securities between April 21, 2023 through April 30, 2025 (“the Class Period”).         Follow the link below for more information:
By Kirby McInerney LLP · Via GlobeNewswire · January 13, 2026
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages F5, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FFIV
NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · January 13, 2026
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Ardent Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ARDT
NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · January 13, 2026
Altus Group Announces Completion of Substantial Issuer Bid
TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Altus Group Limited (“Altus Group”) (TSX: AIF), a leading provider of commercial real estate (“CRE”) intelligence, today announced that it has taken up and paid for 2,855,696 of its common shares (“Shares”) at a price of C$57.00 per Share (the “Purchase Price”) under Altus Group’s substantial issuer bid (the “SIB”) to repurchase for cancellation a number of its Shares for an aggregate purchase price not to exceed C$350 million.
By Altus Group Limited · Via GlobeNewswire · January 13, 2026
SELCO Community Credit Union Selects eGain AI Knowledge Hub™ and eGain AI Agent™ to Transform Internal Knowledge Management
SUNNYVALE, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) -- eGain Corporation (NASDAQ: EGAN), the leading AI knowledge platform for customer service, today announced that SELCO Community Credit Union has selected the eGain AI Knowledge Hub and AI Agent software to modernize its enterprise knowledge management and empower employees across the organization.
By eGain Corporation · Via GlobeNewswire · January 13, 2026
Amplify ETFs Announces Net Asset Value Adjustment for the Amplify BlackSwan Growth & Treasury Core ETF (SWAN)
CHICAGO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Amplify ETFs today announced that the net asset value (NAV) of the Amplify BlackSwan Growth & Treasury Core ETF (SWAN) was decreased by $1.2713 per share on Friday, Jan. 9, 2026. This adjustment is a result of a security pricing error in calculating the Fund’s NAV.
By Amplify ETFs · Via GlobeNewswire · January 13, 2026
Stride Announces Date for Second Quarter Fiscal Year 2026 Earnings Call
RESTON, VA, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Stride Inc. (NYSE: LRN) announced today it plans to discuss its second quarter fiscal year 2026 financial results during a conference call scheduled for Tuesday, January 27, 2026 at 5:00 p.m. eastern time (ET). 
By Stride Inc. · Via GlobeNewswire · January 13, 2026
Brookfield Renewable to Issue C$500 Million of Green Bonds
BROOKFIELD, News, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Brookfield Renewable (NYSE: BEP, BEPC; TSX: BEP.UN, BEPC) (“Brookfield Renewable”) today announced that it has agreed to issue C$500 million aggregate principal amount of Series 20 Notes (the “Notes”), due January 15, 2056, which will bear interest at a rate of 5.204% per annum.
AEM United States Ag Tractor and Combine Report | December 2025
Robex Obtains Final Court Approval for Plan of Arrangement
QUÉBEC CITY, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Robex Resources Inc. (“Robex” or the “Company”) is pleased to announce it has obtained a final order from the Québec Superior Court (Commercial Division) approving the previously announced merger with Predictive Discovery Limited (“Predictive”) pursuant to which Predictive, through its direct wholly-owned subsidiary, will acquire all of the issued and outstanding common shares of Robex (“Robex Shares”) by way of a statutory plan of arrangement under the Business Corporations Act (Québec) (“Arrangement”).
By Robex Resources Inc. · Via GlobeNewswire · January 13, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYX
NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ventyx Biosciences, Inc. (“Ventyx” or the “Company”) (NASDAQ: VTYX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · January 13, 2026
BellRing Brands Announces Timing of First Quarter Fiscal Year 2026 Earnings Release and Conference Call
ST. LOUIS, Jan. 13, 2026 (GLOBE NEWSWIRE) -- BellRing Brands, Inc. (NYSE:BRBR) today announced it will release its financial results for the first quarter of fiscal year 2026 and its fiscal year 2026 outlook on February 3, 2026 at 7:00 a.m. ET. The release will be followed by a conference call at 8:30 a.m. ET to discuss the results and outlook. Darcy H. Davenport, President and Chief Executive Officer, and Paul A. Rode, Chief Financial Officer, will participate in the call.
By BellRing Brands, Inc. · Via GlobeNewswire · January 13, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT
NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  ADC Therapeutics SA (“ADC Therapeutics” or the “Company”) (NYSE: ADCT).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · January 13, 2026
AirJoule Technologies Announces Proposed Public Offering of Class A Common Stock
RONAN, Mont., Jan. 13, 2026 (GLOBE NEWSWIRE) -- AirJoule Technologies Corporation (NASDAQ: AIRJ) (“AIRJ” or the “Company”) today announced the commencement of an underwritten public offering of shares of its Class A common stock, par value $0.0001 per share (“Class A common stock”), pursuant to an effective shelf registration statement on Form S-3 (File No. 333-291527) (the “Registration Statement”) previously filed with the U.S. Securities and Exchange Commission (the “SEC”). The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
By AirJoule Technologies Corporation · Via GlobeNewswire · January 13, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Air Products and Chemicals, Inc. - APD
NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Air Products and Chemicals, Inc. (“Air Products” or the “Company”) (NYSE: APD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · January 13, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SNDL Inc. - SNDL
NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of SNDL Inc. (“SNDL” or the “Company”) (NASDAQ: SNDL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · January 13, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST
NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Aquestive Therapeutics, Inc. (“Aquestive” or the “Company”) (NASDAQ: AQST).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · January 13, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Above Foods Ingredients Inc. - ABVE
NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Above Foods Ingredients Inc. (“Above Food” or the “Company”) (NASDAQ: ABVE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · January 13, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Graphic Packaging Holding Company - GPK
NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Graphic Packaging Holding Company (“Graphic Packaging” or the “Company”) (NYSE: GPK).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · January 13, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ
NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  LENZ Therapeutics, Inc. (“LENZ” or the “Company”) (NASDAQ: LENZ).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · January 13, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lakeland Industries, Inc. - LAKE
NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Lakeland Industries, Inc. (“Lakeland” or the “Company”) (NASDAQ: LAKE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · January 13, 2026
Jay Walker Launches “The Jay Walker Podcast,” Premiering on All Podcast Platforms Every Wednesday
The new daily REVIVE series “JAY WALKER” airs at 7:00 PM ET and delivers conversation + tools in a purpose-driven format
By WOAHRAE · Via GlobeNewswire · January 13, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA
NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of XOMA Royalty Corporation (“Xoma” or the “Company”) (NASDAQ: XOMA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · January 13, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ramaco Resources, Inc. - METC
NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ramaco Resources, Inc. (“Ramaco” or the “Company”) (NASDAQ: METC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · January 13, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rezolute, Inc. - RZLT
NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Rezolute, Inc. (“Rezolute” or the “Company”) (NASDAQ: RZLT).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · January 13, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aerovironment, Inc. - AVAV
NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Aerovironment, Inc. (“Aerovironment” or the “Company”) (NASDAQ: AVAV). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · January 13, 2026
NPU Receives $8M Grant to Strengthen Pastoral Leadership and Theological Education
Chicago, January 13, 2026, Jan. 13, 2026 (GLOBE NEWSWIRE) -- North Park University (NPU) has received an $8,184,203 grant from Lilly Endowment Inc. for its seminary, North Park Theological Seminary, to launch One Covenant Community, a collaborative project that aims to cultivate pastoral leadership across the Evangelical Covenant Church (ECC) by strengthening vocational discernment, theological education, credentialing, and lifelong support.  
By North Park University · Via GlobeNewswire · January 13, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ETHZilla Corporation - ETHZ
NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ETHZilla Corporation (“ETHZilla” or the “Company”) (NASDAQ: ETHZ). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · January 13, 2026
Provident Bank CFO Lyons to Retire After Long, Successful Career
A search to name a successor is currently underway
By Provident Bank · Via GlobeNewswire · January 13, 2026
Praxis Precision Medicines Appoints Global Epilepsy Leader Dr. Orrin Devinsky as Head of Clinical Strategy
BOSTON, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced the appointment of world-renowned neurologist and epilepsy authority Dr. Orrin Devinsky, M.D., as Head of Clinical Strategy, a newly created leadership role.
By Praxis Precision Medicines, Inc. · Via GlobeNewswire · January 13, 2026